Anula Jayasuriya

Insider Reports History

Location
Los Altos, CA
Signature
/s/ Alexandra Hernandez, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anula Jayasuriya:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lineage Cell Therapeutics, Inc. Director Stock Option (Right to Buy) 75K 01 Jul 2025 Direct
Jaguar Health, Inc. Director Stock option (right to buy) 21K 08 Oct 2024 Direct

Insider Reports Filed by Anula Jayasuriya

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 21:00
JAGX Jaguar Health, Inc. 08 Oct 2024 1 $0 4 Director 10 Oct 2024, 21:53
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2024 1 $0 4 Director 03 Jul 2024, 17:00
LCTX Lineage Cell Therapeutics, Inc. 29 Dec 2023 1 $10.9K 4 Director 02 Jan 2024, 19:08
JAGX Jaguar Health, Inc. 01 Jul 2023 3 $0 4 Director 14 Aug 2023, 17:55
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2023 1 $0 4 Director 03 Jul 2023, 17:45
JAGX Jaguar Health, Inc. 06 Apr 2023 1 $0 4 Director 06 Apr 2023, 16:26
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 16:15
JAGX Jaguar Health, Inc. 01 Jul 2022 0 $0 3 Director 05 Jul 2022, 17:15
LCTX Lineage Cell Therapeutics, Inc. 01 Jul 2021 1 $0 4 Director 01 Jul 2021, 18:17